Universidad Autónoma de Bucaramanga
🇨🇴Colombia
- Country
- 🇨🇴Colombia
- Ownership
- Private
- Established
- 1952-01-01
- Employees
- -
- Market Cap
- -
- Website
- https://www.unab.edu.co
Clinical Trials
2
Active:0
Completed:0
Trial Phases
2 Phases
Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 2
1 (50.0%)Mesenchymal Stromal Cell Derivatives in the Treatment of Chronic Diabetic Foot Ulcers Type 1 and 2
Phase 1
- Conditions
- Foot Ulcer, Diabetic
- Interventions
- Other: dac-MSCsOther: MSCsDrug: Fitostimoline
- First Posted Date
- 2016-10-24
- Last Posted Date
- 2016-10-24
- Lead Sponsor
- Universidad Autónoma de Bucaramanga
- Target Recruit Count
- 51
- Registration Number
- NCT02943486
CHICAMOCHA 3 - Equivalence of Usual Interventions for Trypanosomiasis (EQUITY)
- First Posted Date
- 2015-02-24
- Last Posted Date
- 2017-07-21
- Lead Sponsor
- Universidad Autónoma de Bucaramanga
- Target Recruit Count
- 500
- Registration Number
- NCT02369978
- Locations
- 🇨🇴
Fundación Oftalmológica de Santander - Clínica Ardila Lulle (FOSCAL), Bucaramanga, Santander, Colombia
News
No news found